Skip to main content
logo
Enfusion, Inc. (ENFN)
Apr 21, 2025 - ENFN was delisted (reason: acquired by CWAN)
10.76
0.00 (0.00%)
Inactive · Last trade price on Apr 17, 2025

Enfusion Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Enfusion stock had an average target of $12.25, with a low estimate of $11.5 and a high estimate of $13.

Price Target: $12.25 (+13.85%)
Analyst Consensus: Buy

Price Target

TargetLowAverageMedianHigh
Price$11.5$12.25n/a$13
Change+6.88%+13.85%n/a+20.82%

Analyst Ratings

The average analyst rating for Enfusion stock from 3 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
241.06M
from 201.61M
Increased by 19.57%
Revenue Next Year
280.22M
from 241.06M
Increased by 16.24%
EPS This Year
0.29
from 0.03
Increased by 845.10%
EPS Next Year
0.37
from 0.29
Increased by 31.25%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
79.57M111.70M150.35M174.54M201.61M241.06M280.22M
Revenue Growth
34.79%40.39%34.60%16.09%15.51%19.57%16.24%
EPS
84.66-2.26-0.100.070.030.290.37
EPS Growth
-----57.73%845.10%31.25%
Forward PE
-----37.6828.70
No. Analysts
-----1110

Revenue Forecast

Revenue202520262027
High252.0M294.0M
Avg241.1M280.2M
Low227.7M262.2M

Revenue Growth

Revenue Growth202520262027
High
25.0%
22.0%
Avg
19.6%
16.2%
Low
12.9%
8.8%

EPS Forecast

EPS202520262027
High0.360.47
Avg0.290.37
Low0.230.29

EPS Growth

EPS Growth202520262027
High
1,081.4%
65.4%
Avg
845.1%
31.2%
Low
645.9%
2.9%